Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4079340 | 1.00 | USP2 (0.54) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL4078173 | 1.00 | USP2 (0.54) | USP2ALDH1A1LMNACYP1A2TSHR | |
| Hydrochloric Acid SCHEMBL9229306 | 0.97 | USP2 (0.52) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL2283858 | 0.97 | — | — | |
| SCHEMBL290618 | 0.92 | — | — | |
| SCHEMBL290856 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL15398546 | 0.82 | — | — | |
| SCHEMBL302071 | 0.82 | ALDH1A1 (0.39) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL4874234 | 0.82 | ALDH1A1 (0.39) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL22444527 | 0.82 | ALDH1A1 (0.39) | USP2ALDH1A1LMNACYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116120554-A | Composition for optical lens material with high refractive index and low thermal expansion coefficient | 益丰新材料股份有限公司 | 2023-05-16 | — | — | CN | claimed |
| US-9556117-B2 | Indole carboxamide derivatives as P2X7 receptor antagonists | ACTELION PHARMACEUTICALS LTD. (CH) | 2017-01-31 | — | — | US | claimed |
| EP-2935211-B1 | INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2016-11-09 | — | — | EP | claimed |
| US-20150344425-A1 | INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2015-12-03 | — | — | US | claimed |
| US-12435051-B2 | Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof | VIVOZON, INC. (KR) | 2025-10-07 | — | — | US | disclosed |
| CN-116120554-B | Composition for optical lens material with high refractive index and low thermal expansion coefficient | 益丰新材料股份有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-116234552-B | Dual modulators of mGluR5 and 5-HT2A receptors and uses thereof | (株)倍宝尊 | 2025-02-25 | — | — | CN | disclosed |
| US-20240360092-A1 | DUAL MODULATOR OF MGLUR5 AND 5-HT2A RECEPTOR, AND USE THEREOF | VIVOZON INC. (KR) | 2024-10-31 | — | — | US | disclosed |
| US-12060339-B2 | Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof | VIVOZON INC. (KR) | 2024-08-13 | — | — | US | disclosed |
| EP-3365334-B1 | BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS | OTSUKA PHARMA CO LTD (JP) | 2024-07-17 | — | — | EP | disclosed |
| EP-4190770-A1 | DUAL REGULATOR FOR MGLUR5 AND 5-HT2A RECEPTORS AND USE THEREOF | Vivozon, Inc. (KR) | 2023-06-07 | — | — | EP | disclosed |
| EP-4190770-A1 | DUAL REGULATOR FOR MGLUR5 AND 5-HT2A RECEPTORS AND USE THEREOF | Vivozon, Inc. (KR) | 2023-06-07 | — | — | EP | disclosed |
| US-4645802-A | MOLDING MATERIALS | EASTMAN KODAK COMPANY (US) | 1987-02-24 | — | — | US | disclosed |
| US-4420581-A | ANTHRAQUINONE DYE CARBOXYLIC ACID MONOMER | EASTMAN KODAK COMPANY (US) | 1983-12-13 | — | — | US | disclosed |
| EP-0009866-B1 | PHENOLIC ESTERAMIDE ANTIOXIDANTS AND THEIR USE | UNIROYAL, INC. (US) | 1982-08-04 | — | — | EP | disclosed |
| US-4305868-A | Phenolic esteramide antioxidants | UNIROYAL, INC. (US) | 1981-12-15 | — | — | US | disclosed |
| US-4267306-A | FIBER-REACTIVE AND TRIAZOLE DYES; BEVERAGE BOTTLES; POLYAMIDES AND CELLULOSE ESTERS; COLORFASTNESS | EASTMAN KODAK COMPANY (US) | 1981-05-12 | — | — | US | disclosed |
| US-4263446-A | Process for making 3-(3,5-dialkyl-4-hydroxyphenyl)propionate esters of hydroxyalkyloxamides | UNIROYAL, INC. (US) | 1981-04-21 | — | — | US | disclosed |
| US-4250078-A | CONTAINING FERRIC OXIDE | EASTMAN KODAK COMPANY (US) | 1981-02-10 | — | — | US | disclosed |
| EP-0009866-A1 | Phenolic esteramide antioxidants and their use | UNIROYAL, INC. (US) | 1980-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12435051-B2 | Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof | GRM5, HTR5A, HTR2A | USP2 2437/4885ALDH1A1 3972/4885LMNA 4783/4885 |
| US-20240360092-A1 | DUAL MODULATOR OF MGLUR5 AND 5-HT2A RECEPTOR, AND USE THEREOF | GRM5, HTR5A, HTR2A | USP2 2437/4885ALDH1A1 3972/4885LMNA 4783/4885 |
| US-20150344425-A1 | INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS | P2RX7, P2RX3, P2RX1 | USP2 4164/4885ALDH1A1 2019/4885LMNA 2785/4885 |
| US-12060339-B2 | Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof | GRM5, HTR5A, HTR2A | USP2 2437/4885ALDH1A1 3972/4885LMNA 4783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.